Insider Stock Trading History of Hoberman Kenneth


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hoberman Kenneth since year 2005. The trader's CIK number is 1573722. At the time of this reporting, Hoberman Kenneth is the Chief Operating Officer of Stemline Therapeutics Inc . (stock ticker symbol STML). See this page for all insider trading activities at Stemline Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Hoberman Kenneth since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-11-26 STML Stemline Therapeutics Inc Sale 26,296 11.85 311,607
2018-03-12 STML Stemline Therapeutics Inc Sale 17,241 17.71 305,338
2018-03-13 STML Stemline Therapeutics Inc Sale 12,746 16.82 214,387
2018-03-07 STML Stemline Therapeutics Inc Sale 3,027 16.55 50,096
2018-02-26 STML Stemline Therapeutics Inc Sale 5,300 17.61 93,333
2018-02-27 STML Stemline Therapeutics Inc Sale 5,726 17.26 98,830
2018-02-15 STML Stemline Therapeutics Inc Sale 1,851 15.67 29,005
2018-01-08 STML Stemline Therapeutics Inc Sale 14,040 13.93 195,577
2017-12-15 STML Stemline Therapeutics Inc Sale 11,943 14.18 169,351
2017-12-18 STML Stemline Therapeutics Inc Sale 40 14.75 590
2017-03-07 STML Stemline Therapeutics Inc Sale 2,342 8.16 19,110
2017-02-27 STML Stemline Therapeutics Inc Sale 4,000 6.97 27,880
2017-02-28 STML Stemline Therapeutics Inc Sale 4,027 7.01 28,229
2017-02-16 STML Stemline Therapeutics Inc Sale 1,508 6.42 9,681
2017-01-10 STML Stemline Therapeutics Inc Sale 9,110 13.82 125,900
2016-03-08 STML Stemline Therapeutics Inc Sale 2,412 5.34 12,880
2016-02-17 STML Stemline Therapeutics Inc Sale 1,503 4.54 6,823
2015-03-19 STML Stemline Therapeutics Inc Option Ex 27,105 4.09 110,859
2015-03-19 STML Stemline Therapeutics Inc Sale 17,307 16.43 284,354
2015-02-18 STML Stemline Therapeutics Inc Sale 1,593 14.02 22,333
2014-09-02 STML Stemline Therapeutics Inc Buy 2,000 10.99 21,976
2014-05-21 STML Stemline Therapeutics Inc Sale 15,250 13.32 203,130
2013-11-26 STML Stemline Therapeutics Inc Sale 3,144 21.27 66,872
2013-11-27 STML Stemline Therapeutics Inc Option Ex 33,973 1.11 37,710
2013-11-25 STML Stemline Therapeutics Inc Sale 14,350 21.94 314,839
2013-11-26 STML Stemline Therapeutics Inc Option Ex 6,967 1.11 7,733
2013-11-25 STML Stemline Therapeutics Inc Option Ex 37,000 1.11 41,070
2013-11-22 STML Stemline Therapeutics Inc Sale 11,523 20.14 232,073
2013-11-22 STML Stemline Therapeutics Inc Option Ex 35,000 1.11 38,850
2013-11-27 STML Stemline Therapeutics Inc Sale 15,411 19.91 306,833

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoberman Kenneth (Chief Operating Officer of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.